Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis.
[LACTRIMS consensus document for the pharmacological treatment of the multiple sclerosis and its clinical variants].
Accuracy of routine fat-suppressed FLAIR and diffusion-weighted images in detecting clinically evident optic neuritis.
[Chronic cough and worsening dyspnea: a case of idiopathic tracheal stenosis].
Neuroimaging biomarkers of neurodegenerative diseases and dementia.
Involvement of Toso in activation of monocytes, macrophages, and granulocytes.
Fatigue in childhood multiple sclerosis.
The effectiveness of fingolimod in a Portuguese real-world population.
Fingolimod does not impair T-cell release from the thymus and beneficially affects Treg function in patients with multiple sclerosis.
Automated patient-specific optimization of three-dimensional double-inversion recovery magnetic resonance imaging.
A basic overview of multiple sclerosis immunopathology.
Functional organization of an Mbp enhancer exposes striking transcriptional regulatory diversity within myelinating glia.
Temperature dependence of water diffusion pools in brain white matter.
Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases.
Specialized housing and transportation needs of adults with multiple sclerosis.
Simultaneous Development of Acute Disseminated Encephalomyelitis and Guillain-Barré Syndrome Associated with H1N1 09 Influenza Vaccination.
MOBP-specific cellular immune responses are weaker than MOG-specific cellular immune responses in patients with multiple sclerosis and healthy subjects.
Pathogenesis of Pediatric Multiple Sclerosis.
Efficacy and safety of beta-interferon in Thai patients with demyelinating diseases.
Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder.
Corneal Sensitivity and Tear Function in Neurodegenerative Diseases.
Microcystic macular oedema confirmed, but not specific for multiple sclerosis.
Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway.
Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system.
Spinal Cord Diffusion-Tensor Imaging and Motor-evoked Potentials in Multiple Sclerosis Patients: Microstructural and Functional Asymmetry.
Pages
« first
‹ previous
…
336
337
338
339
340
341
342
343
344
…
next ›
last »